Filing
Spy
Filing
Spy
Home
About
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
2 holders
Ownership
Activity
2023 Q3
2 of 14 quarters
Total Value
$221.09M
Total Shares
1.31M
Net Share Change
+182.7K
Activity
1 buying
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$191.29M
1.13M
0.8%
ADD
+183.3K
(+19.3%)
Viking Global Investors
$191.29M
1.13M shares
ADD
+183.3K
(+19.3%)
Patient Capital Management
$29.80M
176.3K
1.7%
TRIM
-574
(-0.3%)
Patient Capital Management
$29.80M
176.3K shares
TRIM
-574
(-0.3%)
KRTX — Karuna Therapeutics Inc - FilingSpy